Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

Farhad Jadidi‐Niaragh

15 ta ish

Tabriz University of Medical Sciences

AkademScholarda batafsil koʻrsatkichlar

  1. The role of regulatory T cells in the pathogenesis and treatment of prostate cancer

    Vahid Karpisheh, Seyedeh Mahboubeh Mousavi, Parinaz Naghavi Sheykholeslami +6

    Sharh maqola20219 iqtibos
    ABI

  2. Simultaneous blockade of TIGIT and HIF-1α induces synergistic anti-tumor effect and decreases the growth and development of cancer cells

    Mehrdad Fathi, Simin Bahmanpour, Asal Barshidi +12

    Maqola20217 iqtibos
    ABI

  3. Prostaglandin E2 as a potent therapeutic target for treatment of colon cancer

    Vahid Karpisheh, Afshin Nikkhoo, Mohammad Hojjat‐Farsangi +7

    Sharh maqola20197 iqtibos
    ABI

  4. EP4 receptor as a novel promising therapeutic target in colon cancer

    Vahid Karpisheh, Navneet Joshi, Angelina Olegovna Zekiy +5

    Sharh maqola20207 iqtibos
    ABI

  5. Targeted Silencing of NRF2 by rituximab-conjugated nanoparticles increases the sensitivity of chronic lymphoblastic leukemia cells to Cyclophosphamide

    Atefeh Khodakarami, Mahsa Afsari Kashani, Atefeh Nazer +13

    MaqolaOchiq kirish20236 iqtibos
    ABI

  6. The sensitivity of acute myeloid leukemia cells to cytarabine is increased by suppressing the expression of Heme oxygenase-1 and hypoxia-inducible factor 1-alpha

    Mohammad Reza Sadeghi, Asma Moslehi, Hadiseh Kheiry +11

    Maqola20246 iqtibos
    ABI

  7. RETRACTED: Silencing STAT3 enhances sensitivity of cancer cells to doxorubicin and inhibits tumor progression

    Navneet Joshi, Farnaz Hajizadeh, Ehsan Ansari Dezfouli +11

    Maqola20215 iqtibos
    ABI

  8. Advancing the therapeutic effectiveness of paclitaxel in chronic lymphocytic leukemia through the simultaneous inhibition of NOTCH1 and SF3B1

    Shiva Abolhasani, Armin Mahmoud Salehi Khesht, Atefeh Khodakarami +13

    Maqola20255 iqtibos
    ABI

  9. The role of <scp>SF3B1</scp> and <scp>NOTCH1</scp> in the pathogenesis of leukemia

    Shiva Abolhasani, Seyyed Sina Hejazian, Vahid Karpisheh +5

    Sharh maqola20225 iqtibos
    ABI

  10. Anti‐angiogenic effects of CD73‐specific siRNA‐loaded nanoparticles in breast cancer‐bearing mice

    Ghasem Ghalamfarsa, Ali Rastegari, Fatemeh Atyabi +11

    Maqola20184 iqtibos
    ABI

  11. Pan Cyclin-Dependent Kinase Inhibitors for the Treatment of Breast Cancer

    Sepideh Izadi, Mohammad Hojjat Farsang, Vahid Karpisheh +1

    Maqola20234 iqtibos
    ABI

  12. Silencing of HIF-1α/CD73 axis by siRNA-loaded TAT-chitosan-spion nanoparticles robustly blocks cancer cell progression

    Farnaz Hajizadeh, Sadaf Moghadaszadeh Ardebili, Mahdi Baghi Moornani +12

    Maqola20204 iqtibos
    ABI

  13. T‐cell immunoglobulin and ITIM domain, as a potential immune checkpoint target for immunotherapy of colorectal cancer

    Mehrdad Fathi, Inna Pustokhina, Sergey V. Kuznetsov +5

    Sharh maqola20213 iqtibos
    ABI

  14. Role of microRNAs in epidermal growth factor receptor signaling pathway in cervical cancer

    Nima Hemmat, Ahad Mokhtarzadeh, Mohammad Aghazadeh +3

    Sharh maqola20202 iqtibos
    ABI

  15. Xanthohumol: An underestimated, while potent and promising chemotherapeutic agent in cancer treatment

    Shadi Vesaghhamedani, Farnoosh Ebrahimzadeh, Elnaz Najafi +6

    Sharh maqola20222 iqtibos
    ABI